In type 2 diabetes (T2D), insulin secretion is impaired, marked by a reduced first-phase response and disrupted oscillatory patterns, typically with higher frequency and lower amplitude pulses [19, 20]. The gene discussed is INS; the disease is type 2 diabetes mellitus.